Delivery Order V797D70052-15B10224F00000055

Award Date 4/24/24
Potential Completion Date 10/31/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
PLYMOUTH MTNG, PA 19462, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,696.00 firm-fixed price delivery order awarded to Emergent Devices, Inc. by the Federal Correctional Institution Ashland, a civilian agency, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The order is for NARCAN, an opioid overdose reversal medication. This delivery order supports the agency's healthcare, law enforcement, and public safety missions by providing access to critical overdose prevention and harm reduction resources. Emergent Devices,...
The U.S. government agency, Office of Procurement Operations, awarded a $66,870.72 firm fixed-price delivery order contract to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NALOXONE (NARCAN) NASAL SPRAY 4MG MEDICATION. The contract has an ultimate completion date of June 12, 2025. Emergent Devices holds multiple federal contracts and grant sub-awards to supply NARCAN nasal spray and other naloxone formulations to various government agencies, including the...
This is a delivery order contract awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to purchase NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The contract has a firm fixed price of $15,921.60 and a completion date of May 31, 2024. Emergent Devices holds multiple federal contracts and grant sub-awards to supply naloxone products, including NARCAN, to various government...
The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...
The Department of Homeland Security's Customs and Border Protection awarded Emergent Devices, Inc., a for-profit manufacturer, a $152,712 firm-fixed-price delivery order contract for NARCAN, a naloxone nasal spray used to rapidly reverse opioid overdoses. This order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceutical and hematology products, which runs through August 2028. Emergent Devices has previously provided NARCAN to other federal agencies,...
This is a federal delivery order awarded by the Department of Health and Human Services Indian Health Service to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical products. The $178,164.00 contract is for the purchase of NARCAN nasal spray, a medication that rapidly reverses opioid overdoses. This delivery order is placed against Emergent Devices' Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. No set-aside designation was used. Emergent Devices...
The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The $946,261.44 delivery order contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for a firm fixed price. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has held other contracts to supply this medication...

This is a firm-fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Ashland to Emergent Devices, Inc. (also known as Emergent BioSolutions), a for-profit manufacturer, for the supply of NARCAN (naloxone nasal spray). The order, valued at $1,356.84, is being awarded under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has an expected completion date of October 31, 2024. This contract does not have a set-aside designation. Emergent Devices, as the prime contractor, will be providing the critical opioid overdose reversal medication to support the Department of Justice Bureau of Prisons' healthcare, law enforcement, and public safety missions. The company has previously held similar contracts with other federal agencies, including the Department of Veterans Affairs and the Department of Health and Human Services' Indian Health Service, to supply naloxone products like NARCAN.

Generated 4/25/24, 7:17 PM